Tissue Viability Cut-off
Tissue Viability Cut-off - Related Videos
09:38
Hybrid-Cut: An Improved Sectioning Method for Recalcitrant Plant Tissue Samples
0 Views •
Cited by 22 •
2016
This protocol describes a simple Hybrid-Cut tissue sectioning method that is useful for recalcitrant plant tissues. Good quality tissue sections enable anatomical studies and other biological studies including in situ hybridization (ISH).
05:00
The Cutting and Floating Method for Paraffin-embedded Tissue for Sectioning
0 Views •
Cited by 21 •
2018
Here, we present a protocol to improve paraffin sectioning. This method combines cutting and floating using a simple thermostatic chamber to avoid the transfer process required by the conventional method. As a result, the efficiency and the number of intact paraffin sections were greatly improved.
12:03
Viability Assays for Cells in Culture
0 Views •
Cited by 39 •
2014
Therapeutic compounds are often first examined in vitro with viability assays. Blind cell counts by a human observer can be highly sensitive to small changes in cell number but do not assess function. Computerized viability assays, as described here, can assess both structure and function in an objective manner.
05:47
Counting and Determining the Viability of Cultured Cells
0 Views •
Cited by 19 •
2008
Determining the number of cells in culture is important in standardization of culture conditions and in performing accurate quantitation experiments. In this video, we demonstrate how cells are counted using a hemacytometer.
07:05
Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
0 Views •
Cited by 6 •
2015
A Cartesian bioprinter was designed and fabricated to allow multi-material deposition in precise, reproducible geometries, while also allowing control of environmental factors. Utilizing the three-dimensional bioprinter, complex and viable constructs may be printed and easily reproduced.
FAQs
Transport creates spatial gradients because cells consume oxygen and nutrients while delivery occurs through diffusion or perfusion. As distance from a supplied region increases, local delivery may become insufficient relative to metabolic demand. The resulting transition from adequately supported tissue to impaired or nonviable regions helps researchers evaluate whether a construct can sustain cells throughout its intended volume.
Greater scaffold thickness can increase the distance that oxygen and nutrients must travel before reaching cells. If transport does not match cellular demand across that distance, inner regions may become functionally compromised even when outer regions remain supported. Evaluating thickness against viability therefore helps bioengineers determine whether a design requires altered dimensions, improved transport, or a different architecture.
Pore structure influences how effectively fluids and dissolved nutrients can move through a scaffold, while vascularization can provide delivery pathways within engineered or transplanted tissue. These features change transport performance and can shift the location or extent of poorly supported regions. Comparing architectures with different transport characteristics helps identify designs more likely to maintain viability after fabrication or implantation.
The cut-off reflects a mismatch between the rate at which oxygen and nutrients reach cells and the rate at which cells use them. A construct may therefore contain regions with different functional states rather than behaving uniformly. This relationship connects transport measurements and viability outcomes, helping researchers interpret whether injury or cell loss arises from inadequate delivery under the tested conditions.
Researchers can examine viability across the engineered tissue while considering scaffold thickness, pore structure, vascularization, and the available diffusion or perfusion pathway. They then relate the location of impaired regions to transport performance and cellular demand. This assessment supports prediction of where viability may decline and indicates whether improved perfusion or an alternative architecture should be investigated.
This analysis is useful when designing tissue constructs, selecting scaffold dimensions, interpreting viability assays, or evaluating tissue intended for implantation. It helps distinguish a broadly viable construct from one containing poorly supported regions that may compromise regeneration. The same framework also guides decisions about vascularization, perfusion, and structural changes needed to improve outcomes after fabrication or transplantation.